How has the UK’s health changed since 2001?
Articles on Legal highs
Displaying all articles
Legal drugs mimic popular substances. But when one is banned, another quickly takes its place.
We’ve got better at managing the health risks of traditional drugs of abuse, but novel psychoactive substances, or ‘legal highs’, are a dangerous unknown.
The market for sythnetic cannabinoids, or spice, shows no sign of decreasing.
The Psychoactive Substances Act will have little effect unless it’s backed up by a drugs education programme.
Legal highs are now illegal in the the UK but why has it taken so long for the law to be changed?
Changing drugs laws can have some very unexpected consequences.
As of next month, all legal highs will be banned in the UK when a new law comes into effect. Don’t expect it to work.
Here’s how the Psychoactive Substances Bill will stand in the way of human flourishing.
The government’s “blanket ban” on legal highs goes against the evidence.
Successive governments haven’t always followed expert advice, but they have in the new bill to end ‘legal highs’.
In one respect, the world’s drug problem is not getting much worse. The UN believes that the use of drugs such as cocaine and heroin has stabilised, for example. In fact, the ground in the drugs battle…
A few doors down from my house, a man is selling drugs. He has herbs to smoke that could leave me happy and stoned and various white powders to ingest that could keep me partying all night. All this would…
The past few weeks have seen something of a media feeding frenzy around the supposed massive increase in deaths from “legal highs”. Closer inspection of the facts, some of which needed to be extracted…
The number of deaths caused by a group of mind altering drugs, including mephedrone, has increased over the past three years. And while toxicology reports also link the use of these substances to deaths…
Legal highs that are novel psychoactive substances (NPS) have flooded Britain over the past few years and their use has increased drastically. NPS are cleverly constructed designer drugs often structurally…
Top contributors
-
Senior Lecturer in Criminology, Manchester Metropolitan University
-
DPhil student in neuroscience, University of Oxford
-
Research Co-ordinator, Department of Pharmacy, University of Hertfordshire
-
Lecturer in Sociology, Lancaster University
-
Professor of Law, University of Kent
-
Senior Lecturer in Criminology, University of Kent
-
Chair in Clinical Pharmacology and Therapeutics, University of Hertfordshire
-
Senior Technician, University of Lincoln
-
Principal Lecturer, University of Lincoln
-
Visiting research fellow, Manchester Metropolitan University
-
Hon. Professor Drug Policy, London School of Hygiene & Tropical Medicine
-
Professor of Neuropharmacology, University of Lancashire
-
Professor of Psychology, Edge Hill University
-
Professor of Neuropsychopharmacology, Imperial College London
-
Senior lecturer in Neuropharmacology, University of Hertfordshire